耐药患者-话题@MedSci

#耐药患者#

5篇内容 | 359人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2162193, encodeId=fcc121621930b, content=癌症疫苗与化疗对HLA-A2阳性<a href='/topic/show?id=7003598934b' target=_blank style='color:#2F92EE;'>#晚期非小细胞肺癌#</a><a href='/topic/show?id=daf52906537' target=_blank style='color:#2F92EE;'>#免疫治疗#</a><a href='/topic/show?id=04d580395fc' target=_blank style='color:#2F92EE;'>#耐药患者#</a>的随机开放标签对照研究, objectTitle=Ann. Oncol | 癌症疫苗与化疗对HLA-A2阳性晚期非小细胞肺癌免疫治疗耐药患者的随机开放标签对照研究：ATALANTE-1, objectType=article, longId=795520, objectId=bea5e9552083, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301010/1696948482253_6145188.png, objectUrl=/article/show_article.do?id=bea5e9552083, replyNumber=0, likeNumber=49, createdTime=2023-10-11, rootId=0, userName=litao2022, userId=1ff65466529, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=bea5e9552083, moduleTitle=Ann. Oncol | 癌症疫苗与化疗对HLA-A2阳性晚期非小细胞肺癌免疫治疗耐药患者的随机开放标签对照研究：ATALANTE-1, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bea5e9552083)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=1807569, encodeId=4c0d180e56919, content=<a href='/topic/show?id=04d580395fc' target=_blank style='color:#2F92EE;'>#耐药患者#</a>, objectTitle=Hypertention：难治性高血压与高血压耐药患者的不良结局比较, objectType=article, longId=205228, objectId=b25420522832, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b25420522832, replyNumber=0, likeNumber=37, createdTime=2021-08-18, rootId=0, userName=ligang4439, userId=869698, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b25420522832, moduleTitle=Hypertention：难治性高血压与高血压耐药患者的不良结局比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b25420522832)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807568, encodeId=66ea180e56896, content=<a href='/topic/show?id=04d580395fc' target=_blank style='color:#2F92EE;'>#耐药患者#</a>, objectTitle=乳腺癌病例：辅助内分泌原发耐药患者晚期一线化疗后氟维司群维持治疗的重要性, objectType=article, longId=182240, objectId=4ee518224089, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ee518224089, replyNumber=0, likeNumber=48, createdTime=2020-02-02, rootId=0, userName=ligang4439, userId=869698, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ee518224089, moduleTitle=乳腺癌病例：辅助内分泌原发耐药患者晚期一线化疗后氟维司群维持治疗的重要性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ee518224089)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807567, encodeId=776d180e56713, content=<a href='/topic/show?id=04d580395fc' target=_blank style='color:#2F92EE;'>#耐药患者#</a>, objectTitle=NX方案联合化疗是内分泌耐药患者的重要治疗选择, objectType=article, longId=178555, objectId=69951e8555fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69951e8555fb, replyNumber=0, likeNumber=40, createdTime=2019-12-03, rootId=0, userName=ligang4439, userId=869698, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69951e8555fb, moduleTitle=NX方案联合化疗是内分泌耐药患者的重要治疗选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69951e8555fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807566, encodeId=319f180e56653, content=<a href='/topic/show?id=04d580395fc' target=_blank style='color:#2F92EE;'>#耐药患者#</a>, objectTitle=T790M突变检测，实现EGFR TKI耐药患者的精准治疗, objectType=article, longId=108175, objectId=29721081e5ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29721081e5ad, replyNumber=0, likeNumber=47, createdTime=2018-06-07, rootId=0, userName=ligang4439, userId=869698, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29721081e5ad, moduleTitle=T790M突变检测，实现EGFR TKI耐药患者的精准治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29721081e5ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

耐药患者

2020-05-29

(审核中...)

前往app查看评论内容

癌症疫苗与化疗对HLA-A2阳性#晚期非小细胞肺癌##免疫治疗##耐药患者#的随机开放标签对照研究

Ann. Oncol | 癌症疫苗与化疗对HLA-A2阳性晚期非小细胞肺癌免疫治疗耐药患者的随机开放标签对照研究：ATALANTE-1

2023-10-11发表于上海

ligang4439 (审核中...)

前往app查看评论内容

#耐药患者#

Hypertention：难治性高血压与高血压耐药患者的不良结局比较

2021-08-18

ligang4439 (审核中...)

前往app查看评论内容

#耐药患者#

乳腺癌病例：辅助内分泌原发耐药患者晚期一线化疗后氟维司群维持治疗的重要性

2020-02-02

ligang4439 (审核中...)

前往app查看评论内容

#耐药患者#

NX方案联合化疗是内分泌耐药患者的重要治疗选择

2019-12-03

ligang4439 (审核中...)

前往app查看评论内容

#耐药患者#

T790M突变检测，实现EGFR TKI耐药患者的精准治疗

2018-06-07

科室
- - 订阅+
  - 更多科室
工具
服务